Searched for
KERENDIA
'India has intellectual power to be a leader in biomedical innovation,' says Bayer AGBayer's CEO Bill Anderson believes India can become a top pharmaceutical market. He highlights the need for supportive policy frameworks, i...- Bayer gets nod to market Kerendia for heart failure treatmentBayer has secured approval in India for its therapy Kerendia to treat heart failure. This drug, finerenone, is already used for chronic kid...
- Bayer seeks approval for key heart drug in IndiaPharmaceutical major Bayer has filed for Indian approval of its patented drug finerenone (Kerendia) to treat heart failure patients with LV...
- Buy Ami Organics, target price Rs 2,605: JM FinancialJM Financial has maintained a buy call on Ami Organics with a target price of Rs 2605. Ami Organics, operating in the chemicals sector, rep...
- Sun Pharma inks pact with Bayer to sell drug for chronic kidney diseaseSun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights...
- Bayer steps up India R&D, clinical trials"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...
- Bayer launches pill to treat chronic kidney disease linked to diabetesThe drug, touted as a potential blockbuster drug for the German pharmaceutical firm, will be sold under the brand name Kerendia in India.
- Bayer introduces medication for chronic kidney disease"The major focus of therapy in patients with chronic kidney disease and diabetes is to prevent end-stage renal disease or kidney failure. D...
Load More